Cell toxicity experiment data
The cell toxicity experiment data for Green Red Bio Metabolome classified as ecological bio and Green Bio Extracts classified as
chemical bio are as follows.
Green Red Bio Metabolome stably induce Cell regeneration reactions even if they are Used in large amounts.
This indicates that there is no use It indicates that no restrictions are needed.
Cytotoxic reactions were induced in Green bio extracts as their usage in creased. This indicates that strict usage. Restrictions are required.
Through this experiment, it can be seen that The safety and reliability of the same plant Vary greatly depending on how the active Ingredient is extracted.
KPIS
Vision
Contributing to the realization of a sustainable human society while addressing climate change through the establishment of an ecological bio-industry ecosystem centered on the Green-Red Bio industry.
[Short-Term Goals]
Establish awareness of Green Red Bio Metabolome through Bio Healthcare Service.
Serve 10,000 users annually and achieve $2 billion USD in annual revenue.
[Mid-Term Goals]
Goals
Build a Korean-style Green-Red Bio ecosystem.
Achieve NASDAQ listing.
Establish global hubs for the Green Red Bio ecosystem.
Reach $100 billion USD in annual revenue.
[Long-Term Goals]
Contribute to solving global climate change through the activation of the global Green-Red Bio industry ecosystem.
Achieve a total market size of $3 trillion USD for the Green Red Bio industry ecosystem.
Secure an 8% royalty revenue rate and a 12% global market share.
Step 3 Research
Research
Direction
Analysis of a wider range of plant-derived substances across various growth cycles.
Development of products based on these findings.
Step 4 Research Research and development of new bio-materials.
Market
Demand
Bio-materials applicable to Healthcare 3.0 and 4.0
Bio-materials that integrate the functionalities of food, functional health supplements, and pharmaceuticals
Bio-foods that do not cause environmental pollution and have no cellular side effects
Bio-foods that can extend cellular lifespan and improve cellular health
Bio-materials capable of fundamental cellular therapy without surgery
Realizing carbon neutrality and carbon reduction through the establishment of a plant-based industrial ecosystem.
Eliminating the root causes of environmental pollution through non-chemical manufacturing processes.
Building a sustainable industrial ecosystem by applying nature-based solution technologies through an ecological approach.
Sustainability
Strategy
Addressing the shortcomings of existing food, functional health supplement, pharmaceutical, and cosmetic industry ecosystems through the production of climate-resilient bio-materials.
Providing social solutions through ESG management.
Designing and implementing industries to ensure that the expansion of the consumer market through Positive Green policies connects to climate change responses.
Reducing social costs by building a happiness-oriented society centered on serotonin.
Investment
Scale
Setting an investment target for the establishment of an industrialization model : $ 300 million USD (11.5% equity stake, second-largest shareholder).
Capital acquisition plan for market expansion :
Securing capital through business execution and NASDAQ listing.